Srinivas Akkaraju - 07 Oct 2025 Form 4 Insider Report for Scholar Rock Holding Corp (SRRK)

Reporting relationship: Director
Issuer ticker: SRRK
Reported as of: 07 Oct 2025
Net transaction value: +$9,007,943
SEC form: 4
Accepted by SEC: 16 Dec 2025, 21:07:57 UTC
Prior SEC filing: 07 Oct 2025
Next SEC filing: 17 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Srinivas Akkaraju

Key filing fact

Srinivas Akkaraju filed Form 4 for Scholar Rock Holding Corp (SRRK) on 16 Dec 2025.

Key facts

This page summarizes Srinivas Akkaraju's Form 4 filing for Scholar Rock Holding Corp (SRRK).
5 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 16 Dec 2025, 21:07.

Change

Previous filing in this sequence was filed on 07 Oct 2025.
Current net transaction value: +$9,007,943.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001253170 Primary reporting owner

AKKARAJU SRINIVAS

Relationship: Director
Address: 628 MIDDLEFIELD ROAD, PALO ALTO
Signature: /s/ Srinivas Akkaraju
Signature date: 16 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRRK transaction

Common Stock

Purchase

Transaction value: $503,011
Shares: +12,796
Change %: +2.6%
Price: $39.31
Shares after: 513,235
Date: 07 Oct 2025
Ownership: By Samsara Opportunity Fund, L.P.
Footnotes: F1, F2

SRRK transaction

Common Stock

Purchase

Transaction value: $498,232
Shares: +12,400
Change %: +2.4%
Price: $40.18
Shares after: 525,635
Date: 07 Oct 2025
Ownership: By Samsara Opportunity Fund, L.P.
Footnotes: F2, F3

SRRK transaction

Common Stock

Purchase

Transaction value: $180,391
Shares: +4,403
Change %: +0.84%
Price: $40.97
Shares after: 530,038
Date: 07 Oct 2025
Ownership: By Samsara Opportunity Fund, L.P.
Footnotes: F2, F4

SRRK transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value: $7,826,309
Shares: +1,064,804
Change %: +20%
Price: $7.35
Shares after: 6,367,614
Date: 12 Dec 2025
Ownership: By Samsara BioCapital, L.P.
Footnotes: F5

SRRK holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 21,132
Date: 07 Oct 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SRRK transaction Derivative

Warrants to Purchase Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value: $0
Shares: -1,064,804
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 12 Dec 2025
Ownership: By Samsara BioCapital LP
Underlying class: Common Stock
Underlying amount: 1,064,804
Exercise price: $7.35
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $38.85 to $39.849 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.

Footnote F2

Securities are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opportunity Fund"). Samsara Opportunity Fund GP, LLC ("Samsara Opportunity GP") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the securities held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.

Footnote F3

The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $39.8512 to $40.85 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.

Footnote F4

The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $40.87 to $41.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.

Footnote F5

Securities are directly held by Samsara BioCapital LP ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.